Clinical Impact of Vitamin K Dosing on Sorafenib Treatment for Hepatocellular Carcinoma

Background: Some researchers have suggested that vitamin K enhances the antitumor effect of sorafenib for hepatocellular carcinoma (HCC) in vitro and in vivo. In this study, we examined the clinical impact of vitamin K dosing for sorafenib treatment. Methods: Twenty-nine out of 65 patients treated w...

Full description

Saved in:
Bibliographic Details
Published in:J Cancer
Main Authors: Haruna, Yoshimichi, Hasegawa, Noriko, Imanaka, Kazuho, Kawamoto, Seiichi, Inoue, Atsuo
Format: Artigo
Language:Inglês
Published: Ivyspring International Publisher 2017
Subjects:
Research Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5559959/
https://ncbi.nlm.nih.gov/pubmed/28819398
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.18900
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items